COVID vaccine companies told to focus on KP.2 variant for fall shots, per FDA announcement
byRayhan-
The U.S. Food and Drug Administration (FDA) has recommended that COVID vaccine manufacturers update their formulas for fall doses, in an attempt to target the KP.2 strain of the JN.1 variant.
